Company: LHI
Filing Date: 2025-01-27
Form Type: DRS/A
Source: 0001213900-25-006939
Chunk: 197

Company: Living Homeopathy International Ltd.
Filing Date: 2025-01-27
Form: DRS/A
Chunk 197
---
 shareholders) of the Company’s outstanding share capital has also agreed to enter into a similar lock-up agreement for a period of six (6) months from the date of the offering, subject to certain exceptions, with respect to any shares of capital stock of the Company or any securities convertible or exchangeable for shares of capital stock of the Company, without the prior written consent of the representatives of the Underwriters. See “Underwriting” beginning on page 123 of this prospectus for more information.

The Company is not aware of any plans by any significant shareholders to dispose of significant numbers of the Company’s Ordinary Shares. However, one or more existing shareholders or owners of securities convertible or exchangeable into or exercisable for the Company’s Ordinary Shares may dispose of significant numbers of the Company’s Ordinary Shares in the future. The Company cannot predict what effect, if any, future sales of the Company’s Ordinary Shares, or the availability of Company’s Ordinary Shares for future sale, will have on the trading price of Living Homeopathy’s Class A Ordinary Shares from time to time. Sales of substantial amounts of Living Homeopathy’s Class A Ordinary Shares in the public market, or the perception that these sales could occur, could adversely affect the trading price of Living Homeopathy’s Class A Ordinary Shares.

Rule 144

All of Living Homeopathy’s Class A Ordinary Shares outstanding prior to this offering are “restricted securities” as that term is defined in Rule 144 under the Securities Act and may be sold publicly in the United States only if they are subject to an effective registration statement under the Securities Act or pursuant to an exemption from the registration requirement such as those provided by Rule 144 promulgated under the Securities Act.

In general, under Rule 144 as currently in effect, beginning 90 days after the date of this prospectus, a person who is not deemed to have been Living Homeopathy’s affiliate at any time during the three months preceding a sale and who has beneficially owned restricted securities within the meaning of Rule 144 for more than six months would be entitled to sell an unlimited number of those shares, subject only to the availability of current public information about the Company. A non-affiliate who has beneficially owned restricted securities for at least one year from the later of the date these shares were acquired from the Company or from Living Homeopathy’s affiliate would be entitled to freely sell those shares.

A person who is deemed to be an affiliate of Living Homeopathy and who has beneficially owned “restricted securities” for at least six months would be entitled to